The Advent of Automated, Gene-Engineered TIL Manufacturing
Automating engineered TIL manufacturing in a way that maintains their tumor-fighting capabilities may move this emerging therapeutic class into a commercially reproducible, economically viable therapeutic option. The post The Advent of Automated, Gene-Engineered TIL Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News .
We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.